Myostatin is a member of the transforming growth factor-β (TGF-β) super-family and functions as a negative regulator of muscle growth. Binding of the specific receptor, Activin receptor IIB (Act RIIB), with myostatin or other related TGF-β members, could be inhibited by the activin-binding protein follistatin (Fst) in mammals. Overexpressing Fst in mouse skeletal muscle leads to muscle hypertrophy and hyperplasia. To determine if Fst has similar roles in fish, we generated transgenic zebrafish expressing high levels of zebrafish Fst1 using the promoter of the zebrafish skeletal muscle-specific gene, myosin, light polypeptide 2, skeletal muscle (Mylz2). Independent transgenic zebrafish lines exhibited elevated expression levels of myogenic regulatory genes MyoD and Pax7 in muscle cells. Adult Fst1 overexpressing transgenic zebrafish exhibited a slight body weight increase. The high level of Fst1 expression dramatically increased myofiber numbers in skeletal muscle, without significantly changing the fiber size. Our findings suggest that Fst1 overexpression can promote zebrafish muscle growth by enhancing myofiber hyperplasia. 
Myostatin, a member of the transforming growth factor super-family, has been shown to negatively regulate satellite cell growth and post-natal myogenesis through Pax7 signals [1] . Like other members of the TGF-β superfamily, myostatin is synthesized as a precursor protein consisting of a signal peptide, an amino-terminal propeptide domain (or prodomain) and a carboxy-terminal mature (active) domain. The precursor undergoes two proteolytic processing events by its proprotein convertases to generate the biologically active molecule. The precursor protein forms a homodimer before proteolytic processing. The cleaved propeptide molecule remains non-covalently bound to the mature domain dimer, forming a latent complex, which inhibits its biological activity by inhibiting myostatin binding to its receptor. It has been reported that myostatin exhibits a pivotal role as a negative regulator of skeletal growth in zebrafish, as do its orthologs in higher vertebrates. In addition, transgenic zebrafish expressing the myostatin prodomain could increase the number of fibers in skeletal muscle [2] [3] [4] .
Follistatin (Fst) is a secreted glycoprotein that was first identified as a potent inhibitor of some members of the TGF-β super-family, because of its strong binding affinity for the receptor protein, activin [5, 6] . It can also directly bind some TGF-β ligand proteins at lower affinities compared to activin in mammals [6] [7] [8] . Fst can block the activity of growth differentiation factor (GDF-11) and myostatin via competitive binding. Fst knockout mice have reduced muscle mass at birth [9] , whereas mice overexpressing Fst in skeletal muscle showed a gross increase in muscle fiber hyperplasia and hypertrophy, compared to wild-type animals [10, 11] .
The cyprinid zebrafish (Danio rerio) was recently shown to have two Fst genes, Fst1 and Fst2. Fst1 is universal among teleosts, and is closely related to the single gene of higher vertebrates. During the embryonic stage, zebrafish Fst1 is initially expressed in the anterior somite before becoming restricted to the external cell layer. Furthermore, Fst1 is strongly expressed in the ventral region of rostral somites, which produces presumptive myogenic precursors of muscles, suggesting a potential role of Fst1 in myogenesis in cyprinids [12] . Fst's inhibitory function on GDFs and the enhanced muscle growth phenotypes caused by the overexpression of Fst in mice, prompted us to produce Fst1 overexpressing zebrafish, with the Fst1 driven by the mylz2 promoter, a strong zebrafish skeletal muscle-specific promoter [13] . The Fst1 transgenic zebrafish had only a slightly increased body weight; however, Fst1 overexpression indeed enhanced MyoD and Pax7 expression in adult transgenic fish skeletal muscle. Furthermore, skeletal muscle growth of the transgenic zebrafish overexpressing Fst1 was significantly enhanced, with a significant increase in numbers of myofibers. Thus, a negative regulatory role for Fst in myostatin-related hyperplasia of muscle in cyprinids is suggested, similar to its orthologs in amniotes.
Materials and methods

Transgenic construction
The zebrafish mylz2:EGFP transgenic construct was previously described and kindly provided by Dr. Gong ZhiYuan from National University of Singapore [13] . The Tol2 enhancer trap vector described previously was kindly provided by Dr. Korzh V. of the Institute of Molecular and Cellular Biology in Singapore [14] . A fragment containing the multiple cloning site (MCS) and SV40 polyadenylation sequence from pCMV-HA vector (Clontech, PT3285, bp829-1049) was amplified using forward primer (5′-ggatccaccatgtacccatacgatgttccagattacgct-3′) and reverse primer (5′-ggatcctttattgcagcttataatggtt-3′), which both contain a BamH I recognition site (underlined). The amplified fragment was then cloned into BamH I-digested mylz2:EGFP to make our muscle expression intermediate vector. After a series of Xba I digestion, filling-in with the Klenow fragment and self-ligation, we gradually destroyed the Xba I site within our intermediate construct. The fragment containing the mylz2 promoter region, the MCS, and SV40 polyadenylation sequence was then amplified with the forward primer (5′-aattcgccacagaggaatg-3′) and reverse primer (5′-tttattgcagcttataatggtt-3′), both containing an Xba I recognition sites. The amplified fragment was then cloned into Xba I-digested Tol2 enhancer trap vector to make our muscle specific promoter, and keratin8 basal promoter driven EGFP expression vector (MHK vector). This MHK vector contains an MCS originally from pCMV-HA vector. Finally, a full-length cDNA of zebrafish Fst1 was cloned via RT-PCR from a zebrafish embryonic total RNA sample. Two oligonucleotide primers, forward primer (5′-atgaattcggatgctaaggatgctaaagcg-3′) containing a EcoR I recognition site (underlined), and reverse primer (5′-atctcgagctacttgtcgtc atcgtctttgtagtc ggcgcacacagcttcctccg-3′) containing a Xho I recognition site (underlined) and a tag peptide coding region (italic), were used to amplify a 0.9 kb of Fst1 coding region based on the zebrafish Fst1 mRNA deposited in GenBank (Accession No. NM_131037). The amplified Fst1 products were cloned into the MHK vector, where Fst1 expression was driven by the zebrafish mylz2 promoter. The SV40 polyadenylation sequence for transcription termination of Fst1 expression was followed by an epithelial specific EGFP expression unit controlled by zebrafish keratin8 promoter, which could be used as a linked reporter gene product for positive gene integration screening ( Figure 1A) . The Tol2 arms flanking the Mylz2 promoter, zebrafish Fst1 coding region, SV40 polyadenylation sequence, keratin8 promoter, EGFP coding region and SV40 polyadenylation sequence were used to enhance genome integration [14] .
Production of transgenic fish
The medaka transposase cDNA clone [14] was kindly provided by Dr. Korzh V. Ten nanograms of MHK-Fst1 plasmid DNA with 25 ng of in vitro synthesized transposase mRNA was co-injected into zebrafish embryos at the one-or two-cell stage, as previously described by Parinov et al. [14] . Expression of GFP in the injected embryos was observed and photographed under a Leica fluorescence microscope.
Injected embryos with epithelial EGFP expression were allowed to grow and cross with wild-type fish. For each F1 cross, at least 100 embryos were examined under a fluorescence microscope. The presence of the transgene fragment was tested by PCR amplification using fish genomic DNA as the template and forward primer (within the mylz promoter region) 5′-TCAGTGGCTACAGCTCATTCA-3′ and reverse primer (within the zfFst1 coding region) 5′-TTTGTCTGGTCCACCACGCAA-3′. The expected size of the amplified fragment was 981 bp. The identified transgenic founders were then crossed with wild-type fish for the analysis.
Whole-mount in situ hybridization
Whole-mount in situ hybridization using a digoxigenin (DIG)-labeled riboprobe was carried out as previously described [15] . The zebrafish Fst1 cDNA clone was amplified as above and cloned into pBluescript vector [13] . The plasmid was linearized with BamH I, followed by an in vitro transcription reaction with T7 RNA polymerase to generate the antisense RNA probe. The embryos/larvae up to five days post fertilization (dpf) were fixed in 4% paraformaldehyde, and hybridized with the DIG-labeled riboprobe in hybridization buffer [50% formamide, 5×SSC (1×=15 mmol L −1 NaCl, 15 mmol L −1 sodium citrate, pH 7.6), 50 mg heparin, 50 mg mL −1 tRNA and 0.1% Tween] at 70°C. They were then incubated with anti-DIG antibody conjugated with alkaline phosphatase and stained with nitroblue phosphate (NBT) and 5-bromo, 4-chloro, 3-indolil phosphate (BCIP) to produce purple and insoluble precipitates.
RNA isolation and real-time PCR
The levels of Fst1, MyoD and Pax7 in non-transgenic control or Fst1 transgenic fish were quantitatively analyzed using real-time PCR at 60 dpf. About 100 mg of muscle tissue was used for total RNA extraction with Trizol reagent, following the procedure recommended by the manufacturer (Invitrogen). The total RNA was digested with RNase-free DNAase to remove endogenous DNA contamination. Firststrand cDNA was synthesized by reverse transcriptase using a SuperScript ® III platinum One-step qRT-PCR Kit (Invitrogen). Zebrafish Fst1, MyoD, and Pax7 were detected by amplification using gene-specific primers (Table 1) . Zebrafish β-actin gene expression was also analyzed (producing a 102 bp amplified product) as an internal control using specific primers (Table 1 ). All amplicons were sequenced to confirm the desired products.
Real-time PCR was carried out on a Sequence Detector (PRISM 7700; ABI, Foster City, CA, USA). Each reaction contained 2 μL cDNA and primers at a final concentration of 2 ng μL −1
. The samples were first heated to 50°C for 2 min, followed by 95°C for 10 min. The PCR reaction was carried out for 40 cycles of 95°C for 15 s and 60°C for 1 min. SDS v1.7a software was used to define the cycle in which each sample attained the threshold value. All values were computed using a standard curve and normalized to zebrafish β-actin, which served the internal positive control. 
Growth evaluations and muscle histological analysis
To determine their body weights, all fish were weighted at 30 and 60 dpf. For muscle histological analysis, muscle tissues from ten individual fish from each group at 60 dpf were fixed in Bouin's solution for 10 h followed by routine paraffin sectioning and Hematoxilin/Eosin staining. Vertical sections at the base of the first pin of the pelvic fin were selected for quantification of the muscle fiber number.
Results
Generation of transgenic zebrafish
The MHK-Fst1 plasmid constructs were co-injected with the synthesized medaka transposase mRNA into fish embryos. Seventy-five percent of the injected embryos showed abnormal developmental features and died prior to hatching, possibly as a result of mis-expression of Fst1 during embryonic stages (a representative features of MHK-Fst1 injected F0 embryos are shown in Figure 1C , labeled as a, b, c). However, 45 fish survived to adulthood from among the 180 injected embryos ( Figures 1D and E) . The transgenic founders (F0) were initially screened based on the epithelial EGFP-expression observed under fluorescence microscopy ( Figures 1B and E) . As a result, we obtained 28 F0 fish showing epithelial EGFP expression, and three of them showed germline transmission. Skeletal muscle Fst1-expression was confirmed using a genomic DNA PCR test to ensure the correct insertion within the zebrafish genome.
( Figure 1G ). These germline transmitters were then used to produce F1 generations. The transmission rate of the transgene into the F1 generation varied from 3%-7% ( Figure 1F ). Unlike initial embryos injected with the mylz:fst1 construct, the survival rates of all F1 transgenic strains were not significantly difference from those of non-transgenic fish (Figures 1E and F) . Using real-time PCR, we confirmed that the average relative expression level of Fst1 in 60 dpf transgenic fish skeletal muscle tissue was much higher than that in control zebrafish ( Figure 1H ): about six-fold higher in lines 2 and 3 than in their non-transgenic control sibling fish.
Fish body weight
To determine body weight, we weighed fish at 30 and 60 dpf and compared transgenic fish with their control siblings. At 30 dpf, the body weights of the transgenic fish and the controls were not significantly different. However, at 60 dpf, the average body weight of our Fst1 hemizygous transgenic zebrafish had increased slightly, but significantly (by 8.14%), compared with their non-transgenic sibling controls ( Table 2 ). The observed phenotype was more obvious compared that observed in hemizygous myostatin prodomain transgenic zebrafish, who showed no significant enhancement in body mass [2] . This suggests that Fst1 overexpression has a stronger influence on body mass increase than myostatin prodomain overexpression.
Myogenic gene expression levels in Fst1 overexpressing transgenic zebrafish
To determine if Fst1 overexpression enhances the expression of a myogenic regulatory gene, we analyzed the expression of MyoD in transgenic fish embryos by whole mount in situ hybridization. There was no significant change in MyoD expression in transgenic zebrafish at embryonic stages (data not shown). However, at later stages (60 dpf), we analyzed the expression of MyoD and Pax7 in transgenic zebrafish by quantitative real time RT-PCR. The expression level of MyoD was significantly upregulated in Fst1 adult transgenic zebrafish skeletal muscle tissue compared with its non-transgenic siblings ( Figure 2 ). As MyoD, Pax7 appears to have critical roles as well during satellite cell activation, proliferation, and differentiation. The expression of Pax7 in fish muscle was enhanced in the Fst1 overexpressing zebrafish muscle at 60 dpf stage (Figure 2 ). This result indicated that Fst1 overexpression in skeletal muscle could enhance myogenesis in zebrafish.
Histological analysis of muscle growth
To determine whether or not muscle growth was affected in the Fst1 transgenic fish, samples of representative transgenic fish and their non-transgenic siblings were sectioned to determine fiber size and number at 60 dpf ( Figures 3A  and B) . The number of myofibers from a defined region of the epaxial muscle at the base of the first pin of the pelvic fin was determined by counting them under a microscope at a fixed magnification ( Figures 3C, D, E, F, and G) . The average number of fibers in Fst1 transgenic fish ((604.14 ± 47.76), n=10) was much larger than the corresponding number in non-transgenic control fish ((462.63 ± 32.12), n=10). While a larger number of the myofibers observed in the same region of the muscle tissue of transgenic fish than the ones in control fish, the existence of many small diameter fibers has also been seen obviously in the Fst1 transgenic muscle tissue ( Figures 3D, E , F, and G). The average individual myofiber area from Fst1 transgenic zebrafish was not significantly larger than the same area from their control siblings. These results indicated that the enhanced muscle growth induced by Fst1 overexpression in zebrafish was caused by hyperplastic growth of muscle, not by hypertrophy.
Discussion
In this study, an Fst1 expression construct under the control of the fish skeletal muscle specific promoter, mylz2, was used to investigate the regulatory function of Fst1 in fish muscle development and its potential role in the regulation of fish muscle growth. Microinjection of the mylz2:fst1 construct initially caused a large proportion (75%) of malformations during early embryonic development, which might reflect the critical function of the Fst1 in dorsoventral patterning during zebrafish gastrulation [16] . The remaining 25% of the mylz:fst1 injected embryos survived to adulthood, which might be because of the late and muscle-specific expression properties of the mylz2 promoter.
Our results revealed that muscle-specific Fst1 overexpression significantly enhanced fish muscling ( Figure 3 ). The overexpression of Fst1 also stimulated MyoD and Pax7 expression in the skeletal muscle of transgenic fish (Figure 2 ). Histological analysis also suggested that enhanced skeletal muscle growth in the Fst1-overexpressing fish mainly resulted from myofiber hyperplasia (Figure 3 ). One member of the TGF-β superfamily that has a major role in regulating muscle growth is myostatin. In mammals, homozygous deficiency of myostatin causes an impressive increase in muscle mass. Previously, myostatin activity ablation in zebrafish, via RNAi and morpholino injection, also led to a giant phenotype and the upregulation of some key myogenic transcriptional factors during embryonic somitogenesis [3, 4] . However, similarly to a previous transgenic study of myostatin prodomain overexpression [2] , we failed to observe any obvious phenotypic differences or upregulation of MyoD and myf5 in our Fst1-overexpressing transgenic fish until two weeks post-hatch (Table 2 , or via whole mount in situ (data not shown)). However, similar to the results obtained in mice overexpressing Fst in skeletal muscle [10] , muscle growth in adult transgenic zebrafish did increase compared with non-transgenic control fish, indicating increased muscle mass. We found no difference in body weight between transgenic and control animals at the hatching stage, and only a moderate increase in body weight in hemizygous Fst1-overexpressing transgenic fish ( Table  2 ). In contrast to the giant zebrafish phenotype obtained by the ubiquitous inhibition of myostatin activity through egg microinjection, muscle specific inhibition of myostatin or other potential regulatory TGF-β members using the transgenic method seems to show mild effects on body growth. This might be related to late Fst1 overexpression from the Mylz2 promoter, whose transcription is initiated only from 20 hpf [13] . It might also suggest that fish myostatin has a substantial body mass regulation function beyond that in muscle tissue. It has been speculated that Fst1 might block other Fst-sensitive ligands expressed in muscle tissue, such as growth and differentiation factor-11 11, 7, 8) . Previous studies demonstrated that Fst transgenic mice had larger muscle mass increases than transgenic mice overexpressing the dominant negative form the activin receptor B and myostatin prodomain [10, 17] . The expression level of MyoD increased in our adult mylz2:Fst1 transgenic fish, which was not observed in myostatin prodomain-overexpressing transgenic zebrafish [2] . Strong muscling in our mylz2:Fst1 transgenic fish was observed in our histological analysis. Phenotypes related to muscle growth seemed more significant in our Fst1 overexpressing fish compared to the transgenic zebrafish expressing the myostatin prodomain [2] . This might reflect the stronger effect of Fst1 on muscle growth promotion than the myostatin prodomain protein, because Fst has been suggested to be involved in the inhibition of TGF-β members other than myostatin [7, 18] .
Lack of myostatin could lead to an enhanced level of Pax7 expression or an increased number of Pax7-positive muscle precursor cells. It has been suggested that myostatin signals through Pax7 to regulate the pool of muscle precursors [1] . In the present study, we demonstrated that Pax7 expression in skeletal muscle was enhanced by Fst1 overexpression (Figure 2) . Compared with the 10% increase in myofiber number in myostatin prodomain protein transgenic zebrafish described by Xu et al. [2] , Fst1-overexpressing transgenic fish exhibited a 33% increase in numbers of fibers. The proportion of small-diameter fibers in our Fst1 transgenic zebrafish is higher than that observed in their control siblings (Figure 3) , indicating enhanced post-hatch myogenic proliferation or stratified hyperplasia. However, we observed a <10% body weight increase and no obvious fish size difference between Fst1 transgenic fish and controls. This might be because of the non-homozygous background of the transgenic fish that we analyzed. Fst overexpressing mice showed reproductive difficulties [19] , and we also encountered reproductive difficulties in our Fst1 transgenic zebrafish. We have not yet been able to obtain homozygous Fst1 transgenic zebrafish. This might be because of the different mechanisms adopted for modulation of postnatal muscle growth between teleosts and amniotes, in terms of the contributions of hypertrophy or hyperplasia to muscle growth [20] . Muscle mass growth in vertebrates increases by the recruitment of new muscle fibers (hyperplasia), as well as by increasing the size of already existing fibers (hypertrophy) [20, 21] . However, small and slowgrowing fish, like zebrafish, largely rely on stratified hyperplasia; this could explain the low capacity of the Fst transgenic fish to further increase their body size, even with significantly increased stratified hyperplasia.
The production of an F0 generation of Fst-overexpressing transgenic trout was recently reported [22] . Fst overexpression in the muscle of the F0 transgenic trout resulted in increased muscling, almost exclusively by muscle fiber hyperplasia. Our observation of the effect of Fst overexpression on muscle mass is similar to previous studies on promyostatin transgenic zebrafish and Fst transgenic trout [2, 22] . Nevertheless, the present study demonstrated, in vivo, that muscle-specific Fst1 overexpression in zebrafish could enhance muscle growth by upregulating the expression of myogenic factors and enhancing myofiber hyperplasia, probably via negative regulation of the function(s) of myostatin and/or other members of the TGF-β super-family.
